ArticleJournal of cosmetic dermatology2025
The Human-Like Collagen Alpha-1 Type V Peptides Strengthen the Dermal Fiber Network and Improve the Regeneration Ability of Cells.
Article in Journal of cosmetic dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Human-Like Collagen Alpha-1 Type V Peptides Strengthen the Dermal Fiber Network and Improve the Regeneration Ability of Cells.Journal of cosmetic dermatology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCollagen, a major structural component of the skin, decreases with age and is associated with wrinkles, reduced elasticity, sagging, and dryness. While hydrolyzed or marine-derived collagens are widely used in cosmetics, advances in biotechnology have enabled the development of bio-collagen peptides. However, the role of collagen type V-derived peptides in skin biology remains largely unexplored.
aimsIn this study, we generated human-like collagen alpha-1 type V peptides (hCOLVp) and investigated their effects on skin-related parameters. PATIENTS/
methodsCOL5A1-derived peptides with optimized sequences were generated, and a single candidate was identified through screening. Protein expression of collagen types I, III, XVII, and laminin 5 was evaluated in human dermal fibroblasts or keratinocytes. A collagen gel contraction assay and SEM-based microstructural analysis were performed. Finally, a reconstructed human full-thickness skin (RS) model was used to assess peptide penetration and barrier-associated proteins.
resultshCOLVp increased expression of collagen types I, III, XVII, and laminin 5. Treated collagen gels showed greater contractile force and higher fiber density than controls. In RS models, hCOLVp penetrated over time and was associated with increased collagen fibers and upregulated expression of involucrin and transglutaminase-1 (TGase-1), both related to barrier function. In a preliminary clinical trial, hCOLVp improved skin barrier properties, density, and elastic recovery.
conclusionThese findings suggest that hCOLVp contributes to strengthening dermal and epidermal structural networks, thereby supporting skin function and resilience.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.